Healthcare services company Chemed Corporation (NYSE:CHE) announced better-than-expected revenue in Q2 CY2026, with sales up ...
Chemed Corp (CHE) reports robust cash flow and strategic acquisitions, despite facing lead generation and marketing cost challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results